<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0058">
 <label>58</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Abdel-Mohsen</surname>
    <given-names>HT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Omar</surname>
    <given-names>MA</given-names>
   </name>, 
   <name name-style="western">
    <surname>El Kerdawy</surname>
    <given-names>AM</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2019</year>; 
  <volume>179</volume>:
  <fpage>707</fpage>–
  <lpage>22</lpage>.
  <pub-id pub-id-type="pmid">31284081</pub-id>
 </mixed-citation>
</ref>
